TABLE 3.
Vector type | Env construct | Vector titer (AP+ FFU/ml) for indicated target cells:
|
|||
---|---|---|---|---|---|
NIH 3T3 | NIH 3T3/LL2SN | 208F | 208F/LL2SN | ||
Lentiviral | JSRV | <5 | 2.8 × 103 | <5 | 1.5 × 102 |
JSRV-HIV | <5 | 3.7 × 103 | <5 | 9.0 × 102 | |
JSRV-10A1 | <5 | 2.5 × 102 | <5 | 2.5 × 102 | |
JSRV-10A1R− | <5 | 3.0 × 102 | <5 | 3.5 × 102 | |
VSV-G | 5.8 × 104 | 6.4 × 104 | 9.0 × 103 | 1.3 × 104 | |
Oncoretroviral | JSRV | <5 | 2.8 × 105 | <5 | 1.5 × 105 |
JSRV-HIV | <5 | 2.8 × 104 | <5 | 9.0 × 102 | |
JSRV-10A1 | <5 | 8.0 × 102 | <5 | 2.5 × 102 | |
JSRV-10A1R− | <5 | 1.8 × 104 | <5 | 8.5 × 103 | |
VSV-G | 1.4 × 106 | 1.6 × 106 | 8.6 × 105 | 8.0 × 105 |
The methods used were the same as those described in Table 1. The titers shown are the means of the results of two experiments and varied by <10%. NIH 3T3/LL2SN and 208F/LL2SN cells are NIH 3T3 and 208F cells that were transduced with a retroviral vector that expresses human Hyal2.